Sacubitril-Valsartan API - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > Sacubitril-Valsartan API - Global Top Players Market Share and Ranking 2026

Sacubitril-Valsartan API - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-10-09
Report Id: 3177875
Industry: Chemical & Material
Report Page: 103
Chart: 107

PDF Download

Publication Date: 2026-10-09
Report Id: 3177875
Industry: Chemical & Material
Report Page: 103
Chart: 107

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Sacubitril-Valsartan API Definition
1.2 Global Sacubitril-Valsartan API Market Size and Forecast
1.2.1 By Consumption Value, Global Sacubitril-Valsartan API Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Sacubitril-Valsartan API Market Size, 2021-2032
1.2.3 Global Sacubitril-Valsartan API Average Selling Price (ASP), 2021-2032
1.3 Japan Sacubitril-Valsartan API Market Size and Forecast
1.3.1 By Consumption Value, Japan Sacubitril-Valsartan API Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Sacubitril-Valsartan API Market Size, 2021-2032
1.3.3 Japan Sacubitril-Valsartan API Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Sacubitril-Valsartan API Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Sacubitril-Valsartan API Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Sacubitril-Valsartan API Market Share in Global, 2021-2032
1.4.3 Sacubitril-Valsartan API Market Size: Japan VS Global, 2021-2032
1.5 Sacubitril-Valsartan API Market Dynamics
1.5.1 Sacubitril-Valsartan API Market Drivers
1.5.2 Sacubitril-Valsartan API Market Restraints
1.5.3 Sacubitril-Valsartan API Industry Trends
1.5.4 Sacubitril-Valsartan API Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Sacubitril-Valsartan API, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Sacubitril-Valsartan API, Global Market Share by Company, 2021-2026
2.3 Sacubitril-Valsartan API Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Sacubitril-Valsartan API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Sacubitril-Valsartan API Concentration Ratio
2.6 Global Sacubitril-Valsartan API Mergers & Acquisitions, Expansion Plans
2.7 Global Sacubitril-Valsartan API Manufacturers Product Type
2.8 Head Office and Sacubitril-Valsartan API Production Site of Key Manufacturer
2.9 Sacubitril-Valsartan API Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Sacubitril-Valsartan API, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Sacubitril-Valsartan API, Japan Market Share by Company, 2021-2026
3.3 Japan Sacubitril-Valsartan API Sacubitril-Valsartan API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Sacubitril-Valsartan API Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Sacubitril-Valsartan API Capacity by Region
4.3 Global Sacubitril-Valsartan API Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Sacubitril-Valsartan API Production by Region, 2021-2032
4.5 Global Sacubitril-Valsartan API Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
5.1 Sacubitril-Valsartan API Industry Chain
5.2 Sacubitril-Valsartan API Upstream Analysis
5.2.1 Sacubitril-Valsartan API Core Raw Materials
5.2.2 Main Manufacturers of Sacubitril-Valsartan API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Sacubitril-Valsartan API Production Mode
5.6 Sacubitril-Valsartan API Procurement Model
5.7 Sacubitril-Valsartan API Industry Sales Model and Sales Channels
5.7.1 Sacubitril-Valsartan API Sales Model
5.7.2 Sacubitril-Valsartan API Typical Distributors

6 Sights Sacubitril-Valsartan API Market Classification
6.1 Sacubitril-Valsartan API Classification by Type
6.1.1 More than 99%
6.1.2 Less than 99%
6.1.3 by Type, Global Sacubitril-Valsartan API Consumption Value, 2021-2032
6.1.4 by Type, Global Sacubitril-Valsartan API Sales Quantity, 2021-2032
6.1.5 by Type, Global Sacubitril-Valsartan API Average Selling Price (ASP), 2021-2032

7 Sights by Application
7.1 Sacubitril-Valsartan API Segment by Application
7.1.1 Pharmaceuticals
7.1.2 Others
7.2 by Application, Global Sacubitril-Valsartan API Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Sacubitril-Valsartan API Consumption Value, 2021-2032
7.4 by Application, Global Sacubitril-Valsartan API Sales Quantity, 2021-2032
7.5 by Application, Global Sacubitril-Valsartan API Price, 2021-2032

8 Sales Sights by Region
8.1 By Region, Global Sacubitril-Valsartan API Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Sacubitril-Valsartan API Consumption Value, 2021-2032
8.3 By Region, Global Sacubitril-Valsartan API Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Sacubitril-Valsartan API Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Sacubitril-Valsartan API Market Size Market Share
8.5 Europe
8.5.1 Europe Sacubitril-Valsartan API Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Sacubitril-Valsartan API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Sacubitril-Valsartan API Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Sacubitril-Valsartan API Market Size Market Share
8.7 South America
8.7.1 South America Sacubitril-Valsartan API Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Sacubitril-Valsartan API Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Sacubitril-Valsartan API Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Sacubitril-Valsartan API Consumption Value, 2021-2032
9.3 By Country, Global Sacubitril-Valsartan API Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Sacubitril-Valsartan API Market Size, 2021-2032
9.4.2 by Type, United States Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Sacubitril-Valsartan API Market Size, 2021-2032
9.5.2 by Type, Europe Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Sacubitril-Valsartan API Market Size, 2021-2032
9.6.2 by Type, China Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Sacubitril-Valsartan API Market Size, 2021-2032
9.7.2 by Type, Japan Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Sacubitril-Valsartan API Market Size, 2021-2032
9.8.2 by Type, South Korea Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Sacubitril-Valsartan API Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Sacubitril-Valsartan API Market Size, 2021-2032
9.10.2 by Type, India Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Sacubitril-Valsartan API Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Sacubitril-Valsartan API Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
10.1 Novartis
10.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis Sacubitril-Valsartan API Models, Specifications, and Application
10.1.3 Novartis Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Novartis Company Profile and Main Business
10.1.5 Novartis Recent Developments
10.2 Dr. Reddy's Laboratories
10.2.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
10.2.2 Dr. Reddy's Laboratories Sacubitril-Valsartan API Models, Specifications, and Application
10.2.3 Dr. Reddy's Laboratories Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 Dr. Reddy's Laboratories Company Profile and Main Business
10.2.5 Dr. Reddy's Laboratories Recent Developments
10.3 Polpharma
10.3.1 Polpharma Company Information, Head Office, Market Area, and Industry Position
10.3.2 Polpharma Sacubitril-Valsartan API Models, Specifications, and Application
10.3.3 Polpharma Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Polpharma Company Profile and Main Business
10.3.5 Polpharma Recent Developments
10.4 Egis Pharmaceuticals
10.4.1 Egis Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Egis Pharmaceuticals Sacubitril-Valsartan API Models, Specifications, and Application
10.4.3 Egis Pharmaceuticals Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 Egis Pharmaceuticals Company Profile and Main Business
10.4.5 Egis Pharmaceuticals Recent Developments
10.5 Faran Shimi Pharmaceutical
10.5.1 Faran Shimi Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Faran Shimi Pharmaceutical Sacubitril-Valsartan API Models, Specifications, and Application
10.5.3 Faran Shimi Pharmaceutical Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Faran Shimi Pharmaceutical Company Profile and Main Business
10.5.5 Faran Shimi Pharmaceutical Recent Developments
10.6 Sihuan Pharmaceutical
10.6.1 Sihuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sihuan Pharmaceutical Sacubitril-Valsartan API Models, Specifications, and Application
10.6.3 Sihuan Pharmaceutical Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 Sihuan Pharmaceutical Company Profile and Main Business
10.6.5 Sihuan Pharmaceutical Recent Developments
10.7 CSPC Pharmaceutical Group
10.7.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.7.2 CSPC Pharmaceutical Group Sacubitril-Valsartan API Models, Specifications, and Application
10.7.3 CSPC Pharmaceutical Group Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.7.5 CSPC Pharmaceutical Group Recent Developments
10.8 CHIA TAI TIANQING PHARMACEUTICAL GROUP
10.8.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information, Head Office, Market Area, and Industry Position
10.8.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP Sacubitril-Valsartan API Models, Specifications, and Application
10.8.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Profile and Main Business
10.8.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Developments
10.9 Salubris
10.9.1 Salubris Company Information, Head Office, Market Area, and Industry Position
10.9.2 Salubris Sacubitril-Valsartan API Models, Specifications, and Application
10.9.3 Salubris Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 Salubris Company Profile and Main Business
10.9.5 Salubris Recent Developments
10.10 Kelun
10.10.1 Kelun Company Information, Head Office, Market Area, and Industry Position
10.10.2 Kelun Sacubitril-Valsartan API Models, Specifications, and Application
10.10.3 Kelun Sacubitril-Valsartan API Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 Kelun Company Profile and Main Business
10.10.5 Kelun Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Sacubitril-Valsartan API should grow from US$ 1371 million in 2025 to US$ 1805 million by 2032, with a CAGR of 4.0% for the period of 2026-2032.

Sacubitril-Valsartan API refers to the active pharmaceutical ingredients in the combination drug used for the treatment of heart failure. Together, these two compounds work synergistically to improve heart function, reduce the risk of hospitalization due to heart failure, and improve overall survival in patients with heart failure with reduced ejection fraction (HFrEF).

Sacubitril-Valsartan API

According to YH Research, the global market for Sacubitril-Valsartan API should grow from US$ 1371 million in 2025 to US$ 1805 million by 2032, with a CAGR of 4.0% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Sacubitril-Valsartan API market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Sacubitril-Valsartan API market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.

By segment, Pharmaceuticals grew percent to account for percent of the total market sales, and Others grew percent.

Report Scope
This report studies and analyses global Sacubitril-Valsartan API status and future trends, helps the client to determine the Sacubitril-Valsartan API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Sacubitril-Valsartan API, and provides market size (in Kilotons & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Sacubitril-Valsartan API market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (Kilotons)
(2) Global Sacubitril-Valsartan API sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Kilotons)
(3) Japan Sacubitril-Valsartan API sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Kilotons)
(4) Global Sacubitril-Valsartan API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Sacubitril-Valsartan API key producing regions, capacity, production, and year over year growth
(6) Sacubitril-Valsartan API industry chains, upstream, midstream and downstream
Market Segmentation
Market segment by players, this report covers
    Novartis
    Dr. Reddy's Laboratories
    Polpharma
    Egis Pharmaceuticals
    Faran Shimi Pharmaceutical
    Sihuan Pharmaceutical
    CSPC Pharmaceutical Group
    CHIA TAI TIANQING PHARMACEUTICAL GROUP
    Salubris
    Kelun

Market segment by Type, covers
    More than 99%
    Less than 99%

Market segment by Application, can be divided into
    Pharmaceuticals
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Chapter Outline
Chapter 1: to describe Sacubitril-Valsartan API product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Sacubitril-Valsartan API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Sacubitril-Valsartan API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Sacubitril-Valsartan API, percent & CAGR, 2021-2032
Chapter 5: Sacubitril-Valsartan API industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions